Microbix signs distributor for Kinlytic

Microbix Biosystems (TSX:MBX) has landed Riso Pharma to distribute its Kinlytic drug in the Middle East, with Riso guaranteeing to purchase no less than 50,000 vials of the treatment for pulmonary embolism over the next three years. Sales are expected to begin in mid-2010.  “While final pricing for our therapy has not yet been established, [...]

Microbix cleared to sell Kinlytic

Health Canada has issued a drug identification number for Kinlytic, formerly known as urokinase, allowing Microbix Biosystems (TSX:MBX) to sell its clot-busting therapy in Canada and markets worldwide. In a statement, Toronto-based Microbix said it will now submit an application to Health Canada for approval of its recently acquired urokinase inventory and targets its release [...]